Patrick J. Geraghty, MD
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Wednesday, November 15, 2023 |
Presenter
The Sirolimus DCB BTK Era Begins: The SELUTION DCB (From MedAlliance And Cordis): Why The FDA Considered It A Breakthrough Device: Results From Singapore And Europe Are Promising And Justified The Ongoing SELUTION4BTK IDE Trial: Preliminary Results
11:36 AM - 11:41 AM
|
Thursday, November 16, 2023 |
Presenter
Subset Analysis From The TOBA II BTK Trial Of The Tack Device (From Philips) Shows No Loss Of Efficacy With Treatment Of Longer Lesions And A High Percentage Of CTOs
3:18 PM - 3:23 PM
|
Friday, November 17, 2023 |
Presenter
Japanese Multicenter 12-Month Data For Selution Sirolimus DCB Treatment Of Femoropopliteal Lesions Show Unmatched Primary Patency And Freedom From Clinically Driven TLR
7:22 AM - 7:27 AM
|
previous | next |